# PhiTech Bioinformatics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/phitech-bioinformatics

- Industry: Biotechnology
- Headquarters: Turkey
- Website: www.phitech.bio
- Total disclosed funding: $1.1M
- Latest round: Seed (Mar 8, 2024)
- Investors on record: 5

## About

Based in Gebze, Turkey, and founded in 2013, PhiTech Bioinformatics, a.k.a. PhiTech operates as a biotechnology company that focuses on translating genome-wide molecular data into biotechnology solutions primarily for use in precision medicine. In March 2024, PhiTech Bioinformatics raised USD 1.1 million in seed funding led by Arya Women Investment Platform, with participation from Arz Portfolio, Simya VC, Vestel Ventures, and ISTCAPITAL.

The company provides genomic data analysis services for the diagnosis of genetic diseases, the discovery of candidate genes for undiagnosed rare diseases, and yield improvement in agriculture. PhiTech leverages its RNA-Seq workflows to identify differentially expressed genes, differentially spliced regions, genomic variants, and perturbed molecular pathways, among others.

The company plans to use its proceeds from March 2024 funding for go-to-market activities through their foreign offices and to accelerate R&D processes.

## Funding rounds

- Seed, Mar 8, 2024, $1.1M — Vestel Ventures, Arya Women Investment Platform, ISTCAPITAL, Arz Portfolio, Simya VC

## Investors

- Vestel Ventures (https://capitalatlas.ai/funds/vestel-ventures) — Seed
- Arya Women Investment Platform (https://capitalatlas.ai/funds/arya-women-investment-platform) — Seed
- ISTCAPITAL (https://capitalatlas.ai/funds/istcapital) — Seed
- Arz Portfolio (https://capitalatlas.ai/funds/arz-portfolio) — Seed
- Simya VC (https://capitalatlas.ai/funds/simya-vc) — Seed